144 filings
Page 2 of 8
424B5
v7n2 8rr7z
2 Nov 23
Prospectus supplement for primary offering
4:41pm
8-K
43s8856a8nxwdtsttz
2 Nov 23
Allogene Therapeutics Reports Third Quarter 2023 Financial Results and Business Update
4:03pm
8-K/A
02fb31cl
17 Oct 23
Departure of Directors or Certain Officers
4:34pm
8-K
mh2f7p ilfdpv
16 Oct 23
Departure of Directors or Certain Officers
8:31am
8-K
2znvobyn
2 Aug 23
Allogene Therapeutics Reports Second Quarter 2023 Financial Results and Business Update
4:04pm
8-K
jcjb31
21 Jun 23
Other Events
4:05pm
8-K
89494
15 Jun 23
Submission of Matters to a Vote of Security Holders
4:08pm
8-K
cp7krjqdf11lj 4u6
14 Jun 23
Departure of Directors or Certain Officers
8:04am
8-K
khdpuru
7 Jun 23
Other Events
4:16pm
8-K
b88ubn
3 May 23
Allogene Therapeutics Reports First Quarter 2023 Financial Results and Business Update
4:05pm
ARS
5u2u2y
24 Apr 23
Annual report to shareholders
4:11pm
DEFA14A
0xhh4vw73fr
24 Apr 23
Additional proxy soliciting materials
4:09pm
8-K
glwk8zb
20 Apr 23
Departure of Directors or Certain Officers
4:08pm
8-K
mkk kb284aa57
10 Mar 23
Regulation FD Disclosure
4:00pm
S-8
qvaw84l2dx8dz8je
28 Feb 23
Registration of securities for employees
4:27pm
8-K
03o0yw7t2uxuaw fx
28 Feb 23
Allogene Therapeutics Reports Fourth Quarter and Full Year 2022
4:07pm